Plasma from patients with cirrhosis increases tissue plasminogen activator release from vascular endothelial cells in vitro

Liver

Volumn 18, Issue 3, 1998, Pages 186-190

  Hayashi, Takeshi ^a   Kamogawa, Asahi ^a   Ro, Shinsei ^a   Yamaguchi, Kai ^a   Kobayashi, Yutaro ^a   Takahashi, Yasuhito ^a   Murayama, Masahiro ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cirrhosis; Plasminogen activator inhibitor 1 (PAI 1); Tissue plasminogen activator (t PA); Vascular endothelial cell

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRINOLYTIC FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CELL CULTURE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER CIRRHOSIS; LIVER METABOLISM; MALE; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0031817139     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1998.tb00148.x     Document Type: Article

References (16)

1. SUZUKI K, KUSUMOTO H, DEYASHIKI Y, et al. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 1987; 6: 1891-7.
2. DE GROOT P G, SIXMA J J. Role of von Willebrand factor in the vessel wall. Semin Thromb Hemost 1987; 13: 416-24.
3. BOOYSE F M, SCHEINBUKS J, LIN P H, TRAYLOR M, BRUCE R. Isolation and interrelationships of the multiple molecular tissue-type and urokinase-type plasminogen activator forms produced by cultured human umbilical vein endothelial cell. J Biol Chem 1988; 283: 15129-38
4. SPRENGERS E D, KLUFT G. Plasminogen activator inhibitor. Blood 1987; 69: 381-7.
5. YANAGISAWA M, KURIHARA H, KIMURA S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-5.
6. TRAN-THANG C, FASEL-FELLEY J, PRALONG G, HOFSTETTER J R, BACHMANN F, KRUITHOF E K O. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis. Thromb Haemost 1989; 62: 651-3.
7. BOKS A L, BROMMER E J P, SCHALM S W, VAN VLIET H H D M. Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage. Hepatology 1986; 6: 79-86.
8. HAYASHI T The mechanism for elevation of plasma tissue plasminogen activator levels in patients with liver cirrhosis: analysis of release response to endothelial cell stimulation during venous occlusion (in Japanese). Acta Hepat Jap 1994; 35: 841-8.
9. JAFFE F A, NACHMAN R L, BECKER C G, MINICK C R. Culture of human endotholial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745-56.
10. KORNINGER C, STSSEN J W, COLLEN D. Turnover of human extrinsic (tissue-type) plasminogen activator in rabbits. Thromb Haemost 1981; 46: 658-61.
11. FUCHS H E, HERGER JR H, PIZZO S V. Catabolism of human tissue plasminogen activator in mice. Blood 1985; 65 539-44.
12. EINARSSON M, SMEDSROD B, PERTOFT O. Uptake and degradation of tissue plasminogen activator in rat liver. Thromb Haemost 1988; 50: 474-9.
13. BAKKER C M, METSELAAR H J, GROENLAND T N, et al. Increased tissue-type plasminogen activator activity in orthotopic but not heterotopic liver transplantation: the role of the anhepatic period. Hepatology 1992; 16: 404-8.
14. TAKAHASHI H, TATEWAKI W, WADA K, YOSHIKAWA A, SHIBATA A. Thrombin and plasmin generation Ln patients with liver disease. Am J Hematol 1989; 32: 30-5.
15. TAKAHASHI H, TATEWAKI W, WADA K, NIWANO H, SHIBATA A. Fibrinolysis and fibrinogenolysis in liver disease. Am J Hematol 1990; 34: 241-5.
16. KEMKES-MATTHES H, BLEYL H, MATTHES K J. Coagulation activation in liver disease. Thromb Res 1991; 64: 253-61.